Below is where the judges will be focusing their scores. Write your entries accordingly.

Judging criteria

Executive Summary – 200 words (not scored)

• If you are nominated for an award, PMGroup may publish extracts from this summary, so ensure that it contains no confidential or sensitive information. No other part of your entry will be reproduced and the main content of your entry will remain confidential at all times.

Clarity of situation analysis and unmet patient needs (10) – 350 words

• Demonstrate how you gained deep and meaningful insights into customer needs and partner’s/partners’ objectives

Clarity and appropriateness of objectives (10) – 300 words

• Demonstrate how your objectives related to all stakeholders and reinforced each other
• Shared objectives, showing rigour and ambition

Quality of strategy development based on insights (15) – 350 words

• Clearly demonstrate how you aimed to address yours and partner’s/partners’ needs in your strategy to improve health outcomes
• Demonstrate what specific insights led to your choice of particular strategy

Quality of execution (10) – 350 words

• Demonstration of true partnership between two or more stakeholders, with shared responsibilities and clear joint outcomes
• Pooled skills, resources and experience

Quality of measurement and learning (10) – 350 words

• Demonstrate how metrics have been applied to measure outcomes, take further action and enable learning
• Demonstrate how data captured is being leveraged and used to adapt strategy and tactics on an ongoing basis

Scalable (10) – 300 words

• Evidence of scalability across the appropriate geographic area

Evidence of improved health outcomes and value (15) – 350 words

• Evidence of customer engagement and positive supportive statements from HCPs
• Evidence of changed perceptions and behaviours that will deliver improved health outcomes

Providers of healthcare services and support (such as patient groups) around the world (such as the NHS in the UK), social care services and the pharmaceutical industry share a common agenda to improve patient care outcomes through highquality, cost-effective treatment and management.

The common agenda is to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment across health and social care. These may be national, international or regional initiatives.

Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery/ improved outcomes. These may have operated at a regional, national or international level.

Potential entrants might include:

• Pharmaceutical, biotech, ethical life science, OTC and medical device/diagnostic company communications teams
• Pharmaceutical company communications teams
• Healthcare agencies and consultancies.
• Providers of healthcare services and support around the world (such as the NHS/Department of Health in the UK).

This category relates to work carried out between January 2022 and June 2023.